FDA — authorised 18 February 1999
- Marketing authorisation holder: SANOFI AVENTIS US
- Status: approved
FDA authorised Glucoferron on 18 February 1999
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA authorised it on 18 February 1999.
SANOFI AVENTIS US holds the US marketing authorisation.